{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:25:14Z","timestamp":1770506714968,"version":"3.49.0"},"reference-count":27,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The identification of a herd of goats with tuberculosis let us test a new treatment regimen against latent tuberculosis infection (LTBI). Using large animal experimental models allows a better approach to understanding human tuberculosis according to immunopathological parameters. Based on an initial study showing a correlation between the ESAT\u20106\u2010specific interferon (IFN)\u2010\u03b3 secretion and the severity of pulmonary lesions, this parameter was used in combination with an X\u2010ray examination to screen the animals to be included in the efficacy and safety studies. All the animals proved to be infected with <jats:italic>Mycobacterium caprae<\/jats:italic>. The efficacy study was run in animals distributed in three experimental groups according to treatment: untreated (CT), treated with isoniazid (INH), and treated with INH\u2003+\u2003RUTI (a vaccine based on <jats:italic>M. tuberculosis<\/jats:italic> cell fragments) inoculated twice. RUTI temporarily increased the IFN\u2010\u03b3 production after stimulating the peripheral blood with ESAT\u20106, purified protein derivative and RUTI <jats:italic>in vitro<\/jats:italic>. The INH chemotherapy reduced both pulmonary and extra pulmonary affectation, but not disease in pulmonary lymph nodes. The addition of RUTI may have decreased extrapulmonar disease further but had no benefit to lung or lung lymph\u2010nodes itself. Safety studies showed that inoculation of RUTI caused a temporary increase of rectal temperature (1\u20132\u2003\u00b0C) and local swelling, both adverse effects being well tolerated. Neither systemic toxicity nor mortality was induced by the vaccination. The control of goats\u2019 infection by the therapeutic regimen consisting in INH chemotherapy\u2003+\u2003RUTI as well as its safety, represented a further step towards testing its effects in human LTBI in a future.<\/jats:p>","DOI":"10.1111\/j.1365-3083.2009.02251.x","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T09:59:38Z","timestamp":1237456778000},"page":"500-507","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effectiveness and Safety of a Treatment Regimen Based on Isoniazid Plus Vaccination with <i>Mycobacterium tuberculosis<\/i> cells\u2019 Fragments: Field\u2010Study with Naturally <i>Mycobacterium caprae<\/i>\u2010Infected Goats"],"prefix":"10.1111","volume":"69","author":[{"given":"M.","family":"Domingo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nofrarias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Vilaplana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.\u2010J.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(98)01216-5"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1992.tb03144.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071367"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1906"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-008-8087-y"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"e_1_2_6_8_2","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock GW","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_6_9_2","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"000","author":"Woldehanna S","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.09.008"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2006.01.024"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00094-08"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1706-1709.2000"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.4.2100-2107.2002"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.4.2192-2198.2003"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104635"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.10.4984-4992.2005"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2007.04.002"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/9781555818357.ch11"},{"key":"e_1_2_6_20_2","volume-title":"Mycobacterium bovis Infection in Animals and Humans","author":"Thoen CO","year":"1995"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.6.3026-3032.2002"},{"key":"e_1_2_6_22_2","first-page":"352","article-title":"Sputum digestion. I. The mortality rate of tubercle bacilli various digestion systems","volume":"45","author":"Krasnow I","year":"1996","journal-title":"Amer J Clin Pathol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1.4.269"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.35.4.907-914.1997"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2004.09.003"},{"key":"e_1_2_6_26_2","first-page":"S231","article-title":"Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946\u20131986, with relevant subsequent publications","volume":"3","author":"Fox W","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/499311"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2007.03.004"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.2009.02251.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.2009.02251.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T16:21:33Z","timestamp":1697300493000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.2009.02251.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,24]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1365-3083.2009.02251.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.2009.02251.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,24]]},"assertion":[{"value":"2009-04-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}